Whitehawk Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +13.0% | +738.8% | +16.7% | -28.1% | -46.9% | +114.5% | |
| – | +14.6% | +709.6% | +19.0% | -30.8% | -50.8% | +143.1% | |
| – | -72.1% | +3,244.3% | -73.8% | +61.2% | -54.4% | +31.0% | |
| – | -72.1% | +3,244.3% | +15.8% | -36.9% | -56.6% | +208.4% | |
| – | +4,866.4% | -100.0% | – | +194.7% | +7.6% | -100.0% | |
| – | – | – | – | +245.4% | -17.4% | -100.0% | |
| – | – | – | – | – | – | – | |
| – | +21.4% | -31.2% | +20.3% | +5.3% | -34.5% | -18.6% | |
| – | +17.3% | -49.2% | +23.3% | +40.1% | -35.3% | -15.0% | |
| – | +9.6% | -98.6% | +200.8% | +10.2% | -38.2% | – | |
| – | -24.7% | +169.2% | -45.3% | +67.6% | -63.4% | -57.5% | |
| – | – | – | – | – | – | – | |
| – | – | – | +16.1% | -33.6% | -50.1% | +159.7% | |
| – | – | – | – | – | – | – | |
| – | +120.0% | -49.4% | +152.3% | +19.6% | +0.4% | +129.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.